Plasma levels of leptin and adiponectin and depressive symptoms in young adults.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
02 2019
Historique:
received: 26 02 2018
revised: 18 09 2018
accepted: 30 11 2018
pubmed: 19 12 2018
medline: 21 5 2019
entrez: 19 12 2018
Statut: ppublish

Résumé

Circulating levels of adipokines are known to be associated with depression. This study aimed to investigate a possible association between leptin, adiponectin and dimensional measures of depressive symptoms in young adults with and without psychiatric illness. Total plasma adiponectin and leptin levels were measured in 194 young adults seeking psychiatric ambulatory care and 57 healthy controls. Depressive symptoms were assessed using the Montgomery-Åsberg Depression Self-Rating Scale (MADRS-S). Analysis was performed on men and women separately. P-leptin levels were significantly elevated in patients compared with controls and correlated with total MADRS-S scores in the women. Women with P-leptin in the highest quartile reached a significantly higher MADRS-S score than women in the lowest quartile, but this difference disappeared after adjusting for body mass index (BMI) and antidepressant use. MADRS-S score was associated with P-leptin in female patients without antidepressant use, independently of BMI. There was no association between P-leptin levels and current major depression. P-adiponectin levels were not associated with depressive symptoms or current major depression. The findings indicate that P-leptin levels are associated with depressive symptom severity in young women; however, the association is linked to other factors, which challenges its usefulness as a biomarker for depression in clinical psychiatry.

Identifiants

pubmed: 30562581
pii: S0165-1781(18)30368-8
doi: 10.1016/j.psychres.2018.11.075
pii:
doi:

Substances chimiques

ADIPOQ protein, human 0
Adiponectin 0
Biomarkers 0
Leptin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Mikaela Syk (M)

Department of Neuroscience, Psychiatry, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.

Sofie Ellström (S)

Department of Neuroscience, Psychiatry, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.

Jessica Mwinyi (J)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.

Helgi B Schiöth (HB)

Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden.

Lisa Ekselius (L)

Department of Neuroscience, Psychiatry, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.

Mia Ramklint (M)

Department of Neuroscience, Psychiatry, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden.

Janet L Cunningham (JL)

Department of Neuroscience, Psychiatry, Uppsala University, Akademiska sjukhuset, 751 85, Uppsala, Sweden. Electronic address: janet.cunningham@neuro.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH